Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve Intimation of Board ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Asston Pharmaceuticals has informed the BSE that its Board of Directors will meet on Friday, 14 November 2025 at 3:00 PM. The key item on the agenda is to consider and approve the un-audited standalone financial results for the half-year ended 30 September 2025 (H1 FY26). Any other agenda items will also be discussed. The company's trading window for designated persons and their immediate relatives remains closed until 17 November 2025, in line with insider trading regulations.
This is a standard pre-results compliance filing. Investors should watch for the H1 FY26 unaudited results, which could influence the stock price once announced. The closed trading window signals that insiders expect material information to be discussed.